Published in Euro Surveill on January 01, 2000
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64
Seroepidemiology of diphtheria and pertussis in Luxembourg in 2000. Epidemiol Infect (2005) 0.90
Report of a pertussis outbreak in a low coverage booster vaccination group of otherwise healthy children in Italy. BMC Infect Dis (2013) 0.77
Immunogenicity and safety of a DTaP-IPV//PRP approximately T combination vaccine given with hepatitis B vaccine: a randomized open-label trial. Bull World Health Organ (2008) 0.77
Pertussis Epidemiology in Greece and Emerging Risk Groups during the Vaccination Era (1980-2008). Adv Prev Med (2012) 0.75
Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol (1994) 2.99
Morphologic, cytogenetic and virologic studies in vitro of a malignant lymphoma from an African child. Int J Cancer (1966) 2.51
Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol (1975) 2.35
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
The effect of interferon on SV-40 T antigen production in SV-40-transformed cells. Virology (1967) 2.13
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA. Science (1968) 2.02
Improved assays for a variety of interferons. 1. Proc Soc Exp Biol Med (1972) 1.79
High interferon producing line of transformed murine cells. J Gen Virol (1972) 1.79
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis (1973) 1.70
Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol (1981) 1.62
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003. Epidemiol Infect (2007) 1.54
The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3. Proc Natl Acad Sci U S A (1965) 1.52
General considerations of the interferon system. Tex Rep Biol Med (1977) 1.52
IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.49
European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine (2003) 1.48
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Kinetics of serum interferon response in mice after single and multiple injections of polyI-poly C. Proc Soc Exp Biol Med (1971) 1.47
A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Inst (1976) 1.42
Identification of a subpopulation of mouse lymphoid cells required for interferon production after stimulation with mitogens. J Immunol (1974) 1.41
Unexpectedly rapid action of human interferon in physiological conditions. Nature (1975) 1.41
Evaluation of an interferon inducer in viral respiratory disease. JAMA (1972) 1.37
Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36
Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice. Nature (1976) 1.35
Some factors affecting the interferon-induced antiviral state. Proc Soc Exp Biol Med (1967) 1.33
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia (2008) 1.33
Interferon-induced transfer of viral resistance between animal cells. Nature (1977) 1.31
Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene (2010) 1.31
Effect of interferon on early interferon production. Science (1966) 1.30
Mechanism of recovery from systemic vaccinia virus infection. I. The effects of cyclophosphamide. J Exp Med (1972) 1.30
Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol (1996) 1.29
Sensitivity of common respiratory viruses to an interferon inducer in human cells. Lancet (1969) 1.29
Growth of Toxoplasma gondii in various tissue cultures treated with In-Cn or interferon. Proc Soc Exp Biol Med (1973) 1.26
Role of interferon in streptococcal infection in the mouse. Microb Pathog (1986) 1.24
Effects of interferon inducers on the intracellular growth of the protozoan parasite, Leishmania donovani. Nature (1970) 1.23
Characterization of the airborne concentrations of lead in U.S. industry. Am J Ind Med (1990) 1.23
Vesicular stomatitis virus plaque production in monolayer cultures with liquid overlay medium: description and adaptation to a one-day, human interferon-plaque. J Clin Microbiol (1976) 1.22
Relationship between dose size and dose interval of polyinosinic polycytidylic acid and interferon hyporesponsiveness in mice. Proc Soc Exp Biol Med (1970) 1.22
Hmx2 homeobox gene control of murine vestibular morphogenesis. Development (2001) 1.22
The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response. Cell Immunol (1976) 1.21
Three strains of influenza A virus (H3N2): interferon sensitivity in vitro and interferon production in volunteers. J Clin Microbiol (1976) 1.21
Antiviral action of mouse interferon in heterologous cells. J Bacteriol (1966) 1.19
Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus. Infect Immun (1975) 1.19
Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). J Infect Dis (1977) 1.19
Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice. J Infect Dis (1980) 1.18
[Evaluation of tracheobronchial lesions with spiral CT: comparison between virtual endoscopy and bronchoscopy]. Radiol Med (2002) 1.17
Interleukin 2 enhances natural killing of normal lymphocytes. Cell Immunol (1984) 1.17
Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon. J Virol (1969) 1.16
IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis. J Immunol (1995) 1.16
Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations. J Natl Cancer Inst (1980) 1.14
Virus-induced sarcoma of mice: inhibition by a synthetic polyribonucleotide complex. Proc Natl Acad Sci U S A (1969) 1.14
Definition and classification of the interferons. Methods Enzymol (1981) 1.14
Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun (1977) 1.13
Broadly active inhibitor of viruses spontaneously produced by many cell types in culture. Infect Immun (1981) 1.12
Rubella virus: role of interferon during infection of African green monkey kidney tissue cultures. J Immunol (1967) 1.12
The effect of an interferon inducer on influenza virus. Bull World Health Organ (1969) 1.10
Interferon: lack of detectable uptake by cells. Science (1966) 1.09
Interferon in rabbit brain, cerebrospinal fluid and serum following administration of polyinosinic-polycytidylic acid. J Immunol (1970) 1.07
Pesticide-related illness among migrant farm workers in the United States. Int J Occup Environ Health (2002) 1.07
Induction of the interferon system by various inducers. Proc Soc Exp Biol Med (1968) 1.05
The biological significance of the interferon system. Arch Intern Med (1970) 1.05
Entamoeba histolytica causes intestinal secretion: role of serotonin. Science (1983) 1.05
Direct cytolysis by partially-purified preparations of immune interferon. Int J Cancer (1982) 1.04
Influence of vaccination coverage on pertussis transmission in France. Lancet (1999) 1.03
Comparative effectiveness of six antiviral agents in Herpes simplex type 1 infection of mice. Proc Soc Exp Biol Med (1976) 1.02
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex. Antimicrob Agents Chemother (1977) 1.01
Protection against herpes virus and encephalomyocarditis virus encephalitis with a double-stranded RNA inducer of interferon. Proc Soc Exp Biol Med (1970) 1.01
Preventing sexual transmission of HIV: anti-HIV bioregulatory and homeostatic components of commercial sexual lubricants. J Biol Regul Homeost Agents (2005) 1.00
Effect of crude and purified interferons on the gowth of uninfected cells in culture. Proc Soc Exp Biol Med (1966) 1.00
Cell-produced viral inhibitor: possible mechanism of action and chemical composition. Infect Immun (1981) 0.99
Inhibitory effect of interferon on murine sarcoma and leukaemia virus infection in vitro. Nature (1969) 0.98
Comparative production of interferon by explanted lymphoreticular tissue and alveolar macrophages from rabbits and humans. Infect Immun (1976) 0.97
[The "Mini-ICF-Rating for Mental Disorders (Mini-ICF-P)". A short instrument for the assessment of disabilities in mental disorders]. Rehabilitation (Stuttg) (2005) 0.97
Role of interferon during viremia. I. Production of circulating interferon. J Immunol (1966) 0.97
Early-appearing antiviral activity in human tears during a case of picornavirus epidemic conjunctivitis. J Infect Dis (1979) 0.97
Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia. J Infect Dis (1979) 0.97
Lipoproteins account for part of the broad non-specific antiviral activity of human serum. Antiviral Res (1999) 0.97
Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis. Infect Immun (1980) 0.97
Role of interferon in murine lactic dehydrogenase virus infection, in vivo and in vitro. Infect Immun (1973) 0.96
Botulism in the European Union. Euro Surveill (1999) 0.96
The effect of an arenavirus infection on liver morphology and function. Am J Trop Med Hyg (1990) 0.96
Interferon: effects on the immune response and the mechanism of activation of the cellular response. CRC Crit Rev Biochem (1976) 0.96
Interferon inhibition of the primary in vitro antibody response to a thymus-independent antigen. Cell Immunol (1975) 0.95
Cost and cost-effectiveness of childhood vaccination against rotavirus in France. Vaccine (2007) 0.95
HIV recovery from saliva before and after dental treatment: inhibitors may have critical role in viral inactivation. J Am Dent Assoc (1993) 0.95
5-iododeoxyuridine potentiation of the replication in vitro of several unrelated RNA and DNA viruses. Science (1975) 0.95
Interferon. Annu Rev Microbiol (1966) 0.95
Induction of tumors in adult hamsters with simian virus 40. J Natl Cancer Inst (1967) 0.94
Mechanisms of DEAE-dextran enhancement of polynucleotide induction of interferon. Proc Soc Exp Biol Med (1971) 0.94
Bone and joint infections in hospitalized patients in France, 2008: clinical and economic outcomes. J Hosp Infect (2012) 0.94
Murine cytomegalovirus: induction of and sensitivity to interferon in vitro. Infect Immun (1975) 0.93
Late therapy with an interferon stimulator in an arbovirus encephalitis in mice. Proc Soc Exp Biol Med (1971) 0.93
Inhibition of human immunodeficiency virus (HIV-1) infection by diphenylhydantoin (dilantin) implicates role of cellular calcium in virus life cycle. Virology (1989) 0.93
Induction of the interferon mechanism by single-stranded RNA: potentiation by polybasic substances. Proc Soc Exp Biol Med (1969) 0.93
Nondetectable levels of interferon gamma is a critical host defense during the first day of herpes simplex virus infection. Microb Pathog (1987) 0.93